跳至主要内容
临床试验/ACTRN12624000122550
ACTRN12624000122550尚未招募Unknown

A feasibility randomised control trial of prolonged virtual reality cycling in people with knee osteoarthritis

The University of South Australia0 个研究点目标入组 40 人开始时间: 2024年2月12日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
45 Years 至 o limit(—)
性别
All

入选标准

  • i) Aged greater than or equal to 45 years
  • ii) Average knee pain intensity of at least 4/10 (overall and/or while walking) over past week using a 0-10 numerical rating scale, where 0 = no pain at all and 10 = worst pain possible
  • iii) Painful knee osteoarthritis at least 6 months duration that meets the National Institute for Health Care Excellence diagnostic criteria for symptomatic knee osteoarthritis (age criteria above, activity-related joint pain, no morning stiffness or stiffness lasting less than 30 minutes)

排除标准

  • i) Conditions that prevent safe participation in physical activity as listed in the American College of Sports Medicine guidelines (e.g., cardiac or lung disease)
  • ii) Pain in other body areas that limits cycling ability (e.g., back pain, foot pain, hip pain)
  • iii) Neurological disorders affecting lower limb movement (e.g., multiple sclerosis, stroke)
  • iv) Inflammatory arthritis (including rheumatoid arthritis)
  • v) Fibromyalgia
  • vi) Previous knee replacement (on most painful knee) or planned knee replacement/surgery (next 6 months) or recent knee replacement on the non- or less-painful knee (<6 months)
  • vii) Previously operated knee is the most painful knee
  • viii) Intra-articular therapy use in the 12 weeks preceding enrolment
  • ix) Any condition impacting decision-making/memory (e.g., Alzheimer’s, dementia)
  • x) Current purposeful exercise of 30 mins or more per day on 5 or more days per week.
  • xi) Unable to commit to study requirements (unable to attend study appointments or complete study outcomes)

研究者

发起方
The University of South Australia

相似试验